The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 08, 2022

Filed:

Jun. 26, 2020
Applicant:

Cepheid, Sunnyvale, CA (US);

Inventors:

Igor V. Kutyavin, Woodinville, WA (US);

Sergey G. Lokhov, Bothell, WA (US);

Assignee:

Cepheid, Sunnyvale, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C12N 9/12 (2006.01); C12N 15/113 (2010.01); C12N 15/115 (2010.01); C12Q 1/686 (2018.01); C12N 9/99 (2006.01); C12N 9/24 (2006.01);
U.S. Cl.
CPC ...
C12N 9/1252 (2013.01); C12N 9/2497 (2013.01); C12N 9/99 (2013.01); C12N 15/113 (2013.01); C12N 15/115 (2013.01); C12Q 1/686 (2013.01); C12N 2310/16 (2013.01); C12N 2310/531 (2013.01); C12Y 207/07007 (2013.01);
Abstract

Provided are methods and compositions for activating oligonucleotide aptamer-deactivated DNA polymerases, comprising modifying the aptamer by uracil-DNA glycosylase enzymatic activity to reduce or eliminate binding of the oligonucleotide aptamer to the DNA polymerase, thereby activating DNA synthesis activity of the DNA polymerase in a reaction mixture. Mixtures for use in methods of the invention are also provided. In some aspects, the oligonucleotide aptamers are circular and comprise one or more deoxyuridine nucleotides providing for aptamer-specific recognition and modification of the circular aptamer by the uracil-DNA glycosylase enzymatic activity. Exemplary oligonucleotide aptamers, mixtures and methods employing uracil-DNA glycosylase enzymatic activity are provided. The methods can be practiced using kits comprising a DNA polymerase-binding oligonucleotide aptamer and at least one uracil-DNA glycosylase enzymatic activity having oligonucleotide aptamer-specific recognition to provide for specific modification of the aptamer by the uracil-DNA glycosylase enzymatic activity.


Find Patent Forward Citations

Loading…